Protein comprising at least one regulatory T cell activating epitope

The present invention relates to the field of immunology, in particular, to the field of modulation of immune responses, in particular, suppression of immune responses and/or induction of tolerance. It provides a tregitope (regulatory T cell activating epitope) carrying polypeptide based on sequence...

Full description

Saved in:
Bibliographic Details
Main Authors WALLMEIER, Holger, HERBENER, Peter, UNGERER, Christopher, KISTNER, Steffen, DAUFENBACH, Jens
Format Patent
LanguageEnglish
Published 01.09.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to the field of immunology, in particular, to the field of modulation of immune responses, in particular, suppression of immune responses and/or induction of tolerance. It provides a tregitope (regulatory T cell activating epitope) carrying polypeptide based on sequences derived from the Fc part of human IgG, wherein said TCP comprises at least one tregitope heterologous to human IgG that is located within at least one of three specific sequence frames. The invention provides such polypeptides for multiple purposes, e.g., in monomeric or dimeric form, wherein both are optionally be linked to an agent, e.g., to which an immune response is to be modulated or suppressed, or co-administered to such an agent, or for use as a stand-alone therapeutic. Nucleic acids encoding the TCP of the invention, pharmaceutic compositions and uses of said TCP are also provided.
AbstractList The present invention relates to the field of immunology, in particular, to the field of modulation of immune responses, in particular, suppression of immune responses and/or induction of tolerance. It provides a tregitope (regulatory T cell activating epitope) carrying polypeptide based on sequences derived from the Fc part of human IgG, wherein said TCP comprises at least one tregitope heterologous to human IgG that is located within at least one of three specific sequence frames. The invention provides such polypeptides for multiple purposes, e.g., in monomeric or dimeric form, wherein both are optionally be linked to an agent, e.g., to which an immune response is to be modulated or suppressed, or co-administered to such an agent, or for use as a stand-alone therapeutic. Nucleic acids encoding the TCP of the invention, pharmaceutic compositions and uses of said TCP are also provided.
Author KISTNER, Steffen
UNGERER, Christopher
HERBENER, Peter
DAUFENBACH, Jens
WALLMEIER, Holger
Author_xml – fullname: WALLMEIER, Holger
– fullname: HERBENER, Peter
– fullname: UNGERER, Christopher
– fullname: KISTNER, Steffen
– fullname: DAUFENBACH, Jens
BookMark eNqNyrsKAjEQBdAUWvj6hwFrwU0WrBcfWFqs9TKE6xKImZCMgn-vgh9gdZozN5MkCTNzuBRRhERe7rmEGtJIrBTBVekzqGB8RFYpL-rJI0Zir-HJ-p3IQSVjaaY3jhWrnwuzPh37_XmDLANqZo8EHbqr3drGtm7n2q5x_603s2g1fw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2021243734A1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2021243734A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:33:26 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2021243734A13
Notes Application Number: AU20210243734
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220901&DB=EPODOC&CC=AU&NR=2021243734A1
ParticipantIDs epo_espacenet_AU2021243734A1
PublicationCentury 2000
PublicationDate 20220901
PublicationDateYYYYMMDD 2022-09-01
PublicationDate_xml – month: 09
  year: 2022
  text: 20220901
  day: 01
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies Biotest AG
RelatedCompanies_xml – name: Biotest AG
Score 3.4245863
Snippet The present invention relates to the field of immunology, in particular, to the field of modulation of immune responses, in particular, suppression of immune...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Protein comprising at least one regulatory T cell activating epitope
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220901&DB=EPODOC&locale=&CC=AU&NR=2021243734A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8NAEB1KFfWmVfGjyoKSWzBpNjY9FGnzQRHaBkmlt5LdbKBQ0pBGxH_vTJpqT72EkA3DZsnLy8zOvAF4FjIm2ShD56bkeOgqPcY3S-eOSqXZE07ao0Lh8eR1NOPvc3vegNWuFqbSCf2uxBERURLxXlbf6_w_iOVVuZWbF7HES-u3IOp7Wu0ddzoG8pvmDft-OPWmrua66Elqkw8aM0l7z-ID9JWO8EfaoQRA_3NIdSn5PqkE53Acor2svICGylpw6u56r7XgZFxveeNpjb7NJXghiSosM0Z54AhOZB0Wl2xF7XfYOlOs2DaWXxc_LGIUkmdUtkBBV7xT5QjeXF3BU-BH7kjH6Sz-nn4xmO3P3bqGZoYWb4ApI-ZdW9q26lncThLhIP1yIZHkE1Ok8hbahyzdHR6-hzNaz206VRuaZfGlHpB_S_FYLdsvRGKJZA
link.rule.ids 230,309,786,891,25585,76894
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8NAEB1KFetNq-JH1QUlt2DTbmxyKNImDVH7haTSW8hut1AoaUgj4r93Jk21p15CyIZhs-TlZWZn3gA8ChmRbFRd54bkeGgpPcI3S-eWmkvDFtbcpkLhwfDZn_C3qTktwXJbC5PrhH7n4oiIKIl4z_LvdfIfxHLz3Mr1k1jgpdWLF7RdrfCOG4068pvmdtu98cgdOZrjoCepDT9ozCDtvSbvoK90gD_ZNint9z67VJeS7JKKdwKHY7QXZ6dQUnEVKs6291oVjgbFljeeFuhbn4E7JlGFRcwoDxzBiazDoowtqf0OW8WKpZvG8qv0hwWMQvKMyhYo6Ip3qgTBm6hzePB6gePrOJ3w7-nDzmR37s0LKMdo8RKYqke8ZUrTVHaTm7OZsJB-uZBI8jNDzOUV1PZZut4_fA8VPxj0w_7r8P0GjmltN6lVNShn6Ze6RS7OxF2-hL_h6oxX
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Protein+comprising+at+least+one+regulatory+T+cell+activating+epitope&rft.inventor=WALLMEIER%2C+Holger&rft.inventor=HERBENER%2C+Peter&rft.inventor=UNGERER%2C+Christopher&rft.inventor=KISTNER%2C+Steffen&rft.inventor=DAUFENBACH%2C+Jens&rft.date=2022-09-01&rft.externalDBID=A1&rft.externalDocID=AU2021243734A1